Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—Specialty & Generic Average - - - - - - 361,929.28 33,163.80 1,575.17 78,530.38 -93.71 0.00 20.6354 52.75 0.3467 -0.7818 0.00 0.02 2.5414 - -
Maximum - - - - - - 9,605,168.00 528,312.00 32,061.00 1,988,352.00 12,901.00 0.05 511.0525 2,720.42 0.9752 0.7155 0.08 1.46 35.1990 - -
Minimum - - - - - - 0.00 0.00 -9,633.00 -277,041.00 -18,385.00 0.00 -791.2164 -853.08 -3.9254 -42.3731 -0.31 -0.90 0.0000 - -
Zoetis Inc. ZTS 175.36 -0.79 -0.45% 1,275 vs. 1,961 79,116.00 2,190.00 599.00 455.00 10,696.00 1.3100 31.9262 0.0026 0.6895 0.2735 0.1184 0.0417 1.7119 451.00
Haleon plc HLN 9.26 -0.25 -2.63% 5,702 vs. 5,211 42,200.00 2,919.00 423.00 0.00 0.00 4.6000 18.0545 0.0000 0.6297 0.1449 0.0253 0.0000 0.0000 4,557.00
Viatris Inc. VTRS 13.00 -0.09 -0.69% 2,972 vs. 7,648 15,516.00 3,656.00 113.00 563.00 4,607.00 0.0953 31.3228 0.0100 0.4157 0.0311 0.0057 0.0024 0.6507 1,193.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for HLNCF and its peers to uncover potential buy and sell opportunities.